Kings Point Capital Management’s VanEck Biotech ETF BBH Stock Holding History

Kings Point Capital Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$44K	Hold	270	–	–	﹤0.01%	366
2021 Q4	$51K	Hold	270	–	–	﹤0.01%	381
2021 Q3	$55K	Hold	270	–	–	﹤0.01%	340
2021 Q2	$54K	Hold	270	–	–	﹤0.01%	339
2021 Q1	$47K	Hold	270	–	–	﹤0.01%	340
2020 Q4	$46K	Hold	270	–	–	﹤0.01%	324
2020 Q3	$44K	Hold	270	–	–	0.01%	323
2020 Q2	$44K	Hold	270	–	–	0.01%	288
2020 Q1	$35K	Hold	270	–	–	0.01%	313
2019 Q4	$38K	Hold	270	–	–	0.01%	344
2019 Q3	$32K	Hold	270	–	–	0.01%	350
2019 Q2	$35K	Hold	270	–	–	0.01%	295
2019 Q1	$35K	Hold	270	–	–	0.01%	264
2018 Q4	$30K	Hold	270	–	–	0.01%	271
2018 Q3	$37K	Hold	270	–	–	0.01%	267
2018 Q2	$32K	Hold	270	–	–	0.01%	275
2018 Q1	$32K	Hold	270	–	–	0.01%	280
2017 Q4	$34K	Hold	270	–	–	0.01%	267
2017 Q3	$36K	Hold	270	–	–	0.01%	244
2017 Q2	$34K	Hold	270	–	–	0.01%	247
2017 Q1	$32K	Hold	270	–	–	0.01%	262
2016 Q4	$29K	Hold	270	–	–	0.01%	235
2016 Q3	$31K	Hold	270	–	–	0.01%	221
2016 Q2	$28K	Buy	+270	New	+$28.8K	0.01%	234
2016 Q1	–	Sell	-270	Closed	-$34K	–	323
2015 Q4	$34K	Hold	270	–	–	0.01%	246
2015 Q3	$31K	Hold	270	–	–	0.01%	267
2015 Q2	$36K	Hold	270	–	–	0.01%	246
2015 Q1	$35K	Hold	270	–	–	0.01%	251
2014 Q4	$31K	Hold	270	–	–	0.01%	246
2014 Q3	$29K	Hold	270	–	–	0.01%	227
2014 Q2	$26K	Hold	270	–	–	0.01%	228
2014 Q1	$25K	Hold	270	–	–	0.01%	212
2013 Q4	$24K	Hold	270	–	–	0.01%	210
2013 Q3	$22K	Buy	+270	New	+$21.2K	0.01%	217

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

Kings Point Capital Management's BBH Position: Q1 2022 in Review

Kings Point Capital Management held its VanEck Biotech ETF (BBH) position steady in Q1 2022 at 270 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Kings Point Capital Management first reported a position in BBH in Q3 2013 and has held it in 34 quarters since. The position peaked at $55K in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2022.

Kings Point Capital Management held 270 shares of VanEck Biotech ETF worth $44K as of Q1 2022.
Kings Point Capital Management left its VanEck Biotech ETF share count unchanged in Q1 2022.
VanEck Biotech ETF made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #366 holding.
Kings Point Capital Management first reported a position in VanEck Biotech ETF in Q3 2013 and has held it in 34 quarters since.
Kings Point Capital Management's VanEck Biotech ETF position peaked at $55K in Q3 2021.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.